Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index; 1 of the 10 sources its claims cite were checked for support.
Abstract
Purpose: Depressive symptoms constitute an important group of mental problems that alter the course of post-stroke rehabilitation by reducing quality of life, physical activity, social functioning, and interpersonal relationships. Although several studies have shown the efficacy of virtual reality (VR) in the motor treatment of poststroke patients, there is a lack of studies that would also evaluate the impact of VR on psychological aspects. Thus, we investigated the effectiveness of immersive VR therapy on both functional activity and depressive symptoms in stroke survivors. Patients and Methods: We conducted a single blind, randomized controlled trial comparing VR therapy with Schultz’s Autogenic Training (SAT). Patients randomized to the VR group received treatment in an immersive VR therapeutic garden with elements of psychotherapy and physical activity of the upper extremities, whereas patients in the control group received SAT. Additionally, patients in both groups received standard neurological rehabilitation. The full research cycle lasted six weeks. We used Geriatric Depression Scale, Generalized Self-Efficacy Scale, Acceptance of Illness Scale, Visual Analogue Scale of pain, Hospital Anxiety and Depression Scale, Barthel Index, Lawton Instrumental Activities of Daily Living Scale and Rivermead Motor Assessment for outcome assessment. This trial was registered with ClinicalTrials.gov (NCT03830372). Results: We assessed 60 patients and randomly assigned to the VR or control group. The VR group showed a significant reduction in depressive symptoms (ηp2 = 0.13, p < 0.01) compared to SAT. The applied VR therapy significantly increased the sense of self-efficacy and the level of acceptance of the illness; however, this effect was similar to that obtained with the standard intervention. We did not observe statistically significant changes in the functional parameters of post-stroke patients. Conclusion: The use of VR therapy combined with neurological rehabilitation had a positive effect on improving mood and reducing depressive symptoms in post-stroke patients. © 2022 Kiper et al.
Overview
CoChat Summary
## TL;DR
This randomized controlled trial found that adding immersive virtual reality (VR) therapy to standard neurological rehabilitation reduced depressive symptoms more than Schultz’s Autogenic Training (SAT) in post-stroke patients. It did not improve functional outcomes more than control treatment, despite significant gains in both groups on some functional scales.
## Key findings
- The study randomized 60 patients (30 VR, 30 control) and found a significant reduction in depressive symptoms in the VR group versus SAT, with ηp² = 0.13, p < 0.01 for the primary depression outcome.
- In the VR group, GDS-30 decreased by 46% at T1 (13.77 vs 7.43) and 48% at T2 (13.77 vs 7.17; p < 0.0001). The control group also improved on GDS-30, but the between-group difference was significant only for GDS-30.
- The VR group showed significant improvements in HADS total (26% at T1; 27% at T2), HADS-A (32% at T1; 25% at T2), and AIS (12% at T1; 16% at T2), while VAS and GSES did not change significantly.
- No superior functional benefit was shown for VR: the paper reports no statistically significant differences between groups for Barthel Index, IADL, or Rivermead Motor Assessment, even though both groups improved over time.
## Methods
- Design: Single-blind randomized controlled trial with a blinded outcome assessor; 6-week course, with outcomes measured at T0, T1 (3 weeks), and T2 (6 weeks).
- Sample/data: 60 stroke survivors aged 55–75 with ischemic stroke and GDS-30 ≥10; excluded if epilepsy, vertigo, MMSE <24, aphasia, major sensory loss, refusal, intellectual disability, or disturbed consciousness.
- Analysis: Intention-to-treat with LOCF for missing data; baseline group comparisons with t-tests/chi-squared, intervention effects with two-way repeated-measures ANOVA (Bonferroni and Greenhouse–Geisser corrections), and Friedman’s ANOVA for VAS.
## Limitations
- The paper explicitly states that 21 participants dropped out after three weeks, so the authors used ITT with LOCF to handle missing data.
- The study included only people with depressive symptoms on the GDS, without a major depressive disorder diagnosis.
- The authors note they used self-reported questionnaires and functional scales only, without more objective measures; they also say effects may differ if participants are not fully “immersed” in the therapy.
- Evident from the text: the trial was stopped at 60 participants because of the COVID-19 outbreak and a rerun power analysis, even though the initial plan called for 80 participants.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 6 Not checked · 20 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants who dropped out from the study had a 64% higher GDS-30 score (11.48 vs 7.23; p = 0.0006).”
- Also stated in: § Discussion · plain
“The GDS-30 score obtained by the participants who dropped out from the study was 64% higher than those who remained.”
§ Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial > Results > Dropout Analysis
plainstates an associationn = 21- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the control group, a statistically significant improvement was shown on the GDS-30, HADS, HADS-A and AIS (Figure 4).”
§ Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial > Results > Effectiveness of Interventions on Psychological Parameters In the VR group, the intervention led to a statistically significant reduction of the GDS-30 score post-treatment (T1, 46%; 13.77 vs 7.43) and at follow-up (T2, 48%; 13.77 vs 7.17; p < 0.0001). For the total HADS, we observed a significant decrease of 26% (14.15 vs 10.40) at T1 and 27% (14.15 vs 10.30) at T2 (p < 0.0001): HADS-A (anxiety) decreased by 32% (7.05 vs 4.80; T1) and 25% (7.05 vs 5.25; T2; p = 0.0018) and HADS-D by 21% at both T1 (7.10 vs 5.60) and T2 (7.10 vs 5.05; p < 0.0057). The AIS score increased by 12% (23.23 vs 26.03) and 16% (23.23 vs 26.97) at T1 and T2, respectively (p = 0.007), resulting in improved well-being of patients. Regarding the VAS and GSES results, no statistically significant change was demonstrated at any time point. In the control group, a statistically significant improvement was shown on the GDS-30, HADS, HADS-A and AIS (Figure 4). Considering the GDS-30 results, after ten interventions, we obtained a reduction of 25% (13.40 vs 20.23) with respect to T1 and 22% (13.40 vs 10.23) with respect to T2 (p < 0.0001). For the total HADS, a statistically significant decrease of 18% was observed at both T1 (15.11 vs 12.26) and T2 (15.11 vs 12.21; p = 0.003). Considering the HADS-A results, after the intervention we obtained reductions of 25% (8.32 vs 6.21) at T1 and 27% (8.32 vs 6.11) at T2. For the AIS score, statistically significant increases of 17% (22.07 vs 25.90) and 18% (22.07 vs 26.20) were observed at T1 and T2, respectively (p < 0.0001). The differences obtained in the VAS, HADS-D and GSES scores were not statistically significant. A within–between analysis (Time*Group, Table 3) indicates that the only statistically significant difference was observed in the GDS-30 (p < 0.0001). There was no statistically significant difference between the groups in the other parameters analysed.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Regarding the VAS and GSES results, no statistically significant change was demonstrated at any time point.”
§ Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial > Results > Effectiveness of Interventions on Psychological Parameters In the VR group, the intervention led to a statistically significant reduction of the GDS-30 score post-treatment (T1, 46%; 13.77 vs 7.43) and at follow-up (T2, 48%; 13.77 vs 7.17; p < 0.0001). For the total HADS, we observed a significant decrease of 26% (14.15 vs 10.40) at T1 and 27% (14.15 vs 10.30) at T2 (p < 0.0001): HADS-A (anxiety) decreased by 32% (7.05 vs 4.80; T1) and 25% (7.05 vs 5.25; T2; p = 0.0018) and HADS-D by 21% at both T1 (7.10 vs 5.60) and T2 (7.10 vs 5.05; p < 0.0057). The AIS score increased by 12% (23.23 vs 26.03) and 16% (23.23 vs 26.97) at T1 and T2, respectively (p = 0.007), resulting in improved well-being of patients. Regarding the VAS and GSES results, no statistically significant change was demonstrated at any time point. In the control group, a statistically significant improvement was shown on the GDS-30, HADS, HADS-A and AIS (Figure 4). Considering the GDS-30 results, after ten interventions, we obtained a reduction of 25% (13.40 vs 20.23) with respect to T1 and 22% (13.40 vs 10.23) with respect to T2 (p < 0.0001). For the total HADS, a statistically significant decrease of 18% was observed at both T1 (15.11 vs 12.26) and T2 (15.11 vs 12.21; p = 0.003). Considering the HADS-A results, after the intervention we obtained reductions of 25% (8.32 vs 6.21) at T1 and 27% (8.32 vs 6.11) at T2. For the AIS score, statistically significant increases of 17% (22.07 vs 25.90) and 18% (22.07 vs 26.20) were observed at T1 and T2, respectively (p < 0.0001). The differences obtained in the VAS, HADS-D and GSES scores were not statistically significant. A within–between analysis (Time*Group, Table 3) indicates that the only statistically significant difference was observed in the GDS-30 (p < 0.0001). There was no statistically significant difference between the groups in the other parameters analysed.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We did not observe statistically significant changes in the functional parameters of post-stroke patients.”
- Also stated in: § Effectiveness of Interventions on Functional Parameters · plain
“The Time*Group analysis did not show statistically significant differences in any of the functional parameters studied, which was also confirmed by post hoc tests (Table 3).”
- Also stated in: § Conclusion · plain
“Finally, the VR intervention with its therapeutic virtual garden did not change the functional aspects. Similar scores on the BI, IADL and RMA scales were observed in both study groups after the intervention and at follow-up measurement.”
§ Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial > Abstract > Results
plainn = 60- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effectiveness of Interventions on Functional Parameters · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The VR group showed a significant reduction in depressive symptoms (ηp2 = 0.13, p < 0.01) compared to SAT.”
- Also stated in: § Effectiveness of Interventions on Psychological Parameters In the VR group, the intervention led to a statistically significant reduction of the GDS-30 score post-treatment (T1, 46%; 13.77 vs 7.43) and at follow-up (T2, 48%; 13.77 vs 7.17; p < 0.0001). For the total HADS, we observed a significant decrease of 26% (14.15 vs 10.40) at T1 and 27% (14.15 vs 10.30) at T2 (p < 0.0001): HADS-A (anxiety) decreased by 32% (7.05 vs 4.80; T1) and 25% (7.05 vs 5.25; T2; p = 0.0018) and HADS-D by 21% at both T1 (7.10 vs 5.60) and T2 (7.10 vs 5.05; p < 0.0057). The AIS score increased by 12% (23.23 vs 26.03) and 16% (23.23 vs 26.97) at T1 and T2, respectively (p = 0.007), resulting in improved well-being of patients. Regarding the VAS and GSES results, no statistically significant change was demonstrated at any time point. In the control group, a statistically significant improvement was shown on the GDS-30, HADS, HADS-A and AIS (Figure 4). Considering the GDS-30 results, after ten interventions, we obtained a reduction of 25% (13.40 vs 20.23) with respect to T1 and 22% (13.40 vs 10.23) with respect to T2 (p < 0.0001). For the total HADS, a statistically significant decrease of 18% was observed at both T1 (15.11 vs 12.26) and T2 (15.11 vs 12.21; p = 0.003). Considering the HADS-A results, after the intervention we obtained reductions of 25% (8.32 vs 6.21) at T1 and 27% (8.32 vs 6.11) at T2. For the AIS score, statistically significant increases of 17% (22.07 vs 25.90) and 18% (22.07 vs 26.20) were observed at T1 and T2, respectively (p < 0.0001). The differences obtained in the VAS, HADS-D and GSES scores were not statistically significant. A within–between analysis (Time*Group, Table 3) indicates that the only statistically significant difference was observed in the GDS-30 (p < 0.0001). There was no statistically significant difference between the groups in the other parameters analysed. · plain
“A within–between analysis (Time*Group, Table 3) indicates that the only statistically significant difference was observed in the GDS-30 (p < 0.0001).”
- Also stated in: § Discussion · hedged
“The findings of this study indicate a reduction of depressive symptoms that was significantly greater in the VR group, along with improvement of the patients’ mental state.”
§ Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial > Abstract > Results
plainstates a causen = 60- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effectiveness of Interventions on Psychological Parameters In the VR group, the intervention led to a statistically significant reduction of the GDS-30 score post-treatment (T1, 46%; 13.77 vs 7.43) and at follow-up (T2, 48%; 13.77 vs 7.17; p < 0.0001). For the total HADS, we observed a significant decrease of 26% (14.15 vs 10.40) at T1 and 27% (14.15 vs 10.30) at T2 (p < 0.0001): HADS-A (anxiety) decreased by 32% (7.05 vs 4.80; T1) and 25% (7.05 vs 5.25; T2; p = 0.0018) and HADS-D by 21% at both T1 (7.10 vs 5.60) and T2 (7.10 vs 5.05; p < 0.0057). The AIS score increased by 12% (23.23 vs 26.03) and 16% (23.23 vs 26.97) at T1 and T2, respectively (p = 0.007), resulting in improved well-being of patients. Regarding the VAS and GSES results, no statistically significant change was demonstrated at any time point. In the control group, a statistically significant improvement was shown on the GDS-30, HADS, HADS-A and AIS (Figure 4). Considering the GDS-30 results, after ten interventions, we obtained a reduction of 25% (13.40 vs 20.23) with respect to T1 and 22% (13.40 vs 10.23) with respect to T2 (p < 0.0001). For the total HADS, a statistically significant decrease of 18% was observed at both T1 (15.11 vs 12.26) and T2 (15.11 vs 12.21; p = 0.003). Considering the HADS-A results, after the intervention we obtained reductions of 25% (8.32 vs 6.21) at T1 and 27% (8.32 vs 6.11) at T2. For the AIS score, statistically significant increases of 17% (22.07 vs 25.90) and 18% (22.07 vs 26.20) were observed at T1 and T2, respectively (p < 0.0001). The differences obtained in the VAS, HADS-D and GSES scores were not statistically significant. A within–between analysis (Time*Group, Table 3) indicates that the only statistically significant difference was observed in the GDS-30 (p < 0.0001). There was no statistically significant difference between the groups in the other parameters analysed. · plain
7 more claims
Create a free account to see all 27 claims and every source verdict.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 13
Citations
Cites
Depression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463
Hackett, M. L., & Pickles, K. (2014) · International Journal of Stroke · doi:10.1111/ijs.12357 · Cited by 1,140 · cited 1×
“In the meta-analysis by Hackett et al comprising 61 studies, the authors observed the incidence of depression in 33% of patients one year post stroke, decreasing to 25% within one to five years’ post stroke and to 23% five years after a stroke event.(11) People with PSD have over three times the risk of death within t…”
Virtual reality for stroke rehabilitation
Laver, K. E., George, S., Thomas, S., Deutsch, J. E., & Crotty, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008349.pub3 · Cited by 1,131
Virtual reality for stroke rehabilitation
Laver, K. E., Lange, B., George, S., Deutsch, J. E., Saposnik, G., & Crotty, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008349.pub4 · Cited by 800
Hoffman, H. G., Chambers, G. T., Meyer, W. J., Arceneaux, L. L., Russell, W. J., Seibel, E. J., Richards, T. L., Sharar, S. R., & Patterson, D. R. (2011) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9248-7 · Cited by 599
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 532 · cited 1×
“On the one hand, antidepressants generate side effects that can ultimately limit the patient’s ability to take them.(10) On the other hand, access to psychotherapy can be limited.”
Background(2001) · Europe PMC (PubMed Central) · Cited by 442
Morina, N., Ijntema, H., Meyerbröker, K., & Emmelkamp, P. M. G. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.08.010 · Cited by 439
Is clinical virtual reality ready for primetime?
Rizzo, A. “., & Koenig, S. T. (2017) · Neuropsychology · doi:10.1037/neu0000405 · Cited by 372
Birckhead, B., Khalil, C., Liu, X., Conovitz, S., Rizzo, A., Danovitch, I., Bullock, K., & Spiegel, B. (2019) · JMIR Mental Health · doi:10.2196/11973 · Cited by 372 · cited 1×
“The design followed recommendations for the third phase (VR3) of VR clinical trials in health care, focusing on the effectiveness of the proposed treatment modality with respect to the control group.(27) This study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.”
Method
Research works printed but not linked: 2
- Schultz, 1950, Med Klin, 45, 945
- Montori, 2001, CMAJ, 165, 1339
Cited by
Immersive Virtual Reality in Post-Stroke Rehabilitation: A Systematic Review
Demeco, A., Zola, L., Frizziero, A., Martini, C., Palumbo, A., Foresti, R., Buccino, G., & Costantino, C. (2023) · Sensors · doi:10.3390/s23031712 · Cited by 220
“When patients are motivated, they actively participate in rehabilitation and are more concentrated on completing the task requested [84,98].”
BackgroundVirtual reality for stroke rehabilitation
Laver, K., Lange, B. S., George, S., Deutsch, J. E., Saposnik, G., Chapman, M., & Crotty, M. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008349.pub5 · Cited by 163
Doré, B., Gaudreault, A., Everard, G. J., Ayena, J. C., Abboud, A., Robitaille, N., & Batcho, C. S. (2023) · Sensors · doi:10.3390/s23052506 · Cited by 75
“, 2022 [47] Randomized controlled trial Geriatric Depression Scale (GDS) VR: Pre-post = +6.”
BackgroundCieślik, B., Juszko, K., Kiper, P., & Szczepańska-Gieracha, J. (2023) · Virtual Reality · doi:10.1007/s10055-023-00797-w · Cited by 71
Self-citationGamified devices for stroke rehabilitation: A systematic review
Sánchez-Gil, J. J., Sáez, A., López-Luque, R., Ochoa-Sepúlveda, J. J., & Cañete, E. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108476 · Cited by 45
Metadata
- Authors
- Kiper, P., Przysiężna, E., Cieślik, B., Broniec-Siekaniec, K., Kucińska, A., Szczygieł, J., Turek, K., Gajda, R., & Szczepańska-Gieracha, J.
- Affiliations
- Wroclaw University of Health and Sport Sciences (PL)
- IRCCS San Camillo Hospital (IT)
- Humanitas University in Sosnowiec (PL)
- Karol Lipiński Academy of Music in Wrocław (PL)
- Jan Długosz University (PL)
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2022-11
- Volume
- Volume 17
- Pages
- 1673-1685
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- PMC
- PMC9701456
- OpenAlex
- W4309715471
- Cited by
- 80
- References
- 53
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 26 · 2023: 10
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Interventions in Aging (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-sa)
- Funders
- Narodowe Centrum Badań i Rozwoju
- Topics
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- post-stroke depression, stroke rehabilitation, autogenic training, self-efficacy, acceptance of illness, depressive symptoms, stroke survivors, upper limb rehabilitation, mood
- MeSH terms
- Stroke Rehabilitation, Activities of Daily Living, Aged, Depression, Humans, Quality of Life, Single-Blind Method, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial. https://app.cochat.ai/papers/10.2147/cia.s375754
- The paper
- Kiper, P., Przysiężna, E., Cieślik, B., Broniec-Siekaniec, K., Kucińska, A., Szczygieł, J., Turek, K., Gajda, R., & Szczepańska-Gieracha, J. (2022). Effects of Immersive Virtual Therapy as a Method Supporting Recovery of Depressive Symptoms in Post-Stroke Rehabilitation: Randomized Controlled Trial. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s375754
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.